chr6-51648115-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_138694.4(PKHD1):c.11314C>T(p.Arg3772*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000633 in 1,580,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_138694.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250698Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135464
GnomAD4 exome AF: 0.00000630 AC: 9AN: 1428200Hom.: 0 Cov.: 25 AF XY: 0.00000421 AC XY: 3AN XY: 712722
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
Autosomal recessive polycystic kidney disease Pathogenic:5
This sequence change in PKHD1 is a nonsense variant predicted to create a premature stop codon, p.(Arg3772*), in biologically relevant exon 63/67 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PMID: 20301501). Loss-of-function variants are a well-established cause of disease in exon 63 (ClinVar). The highest population minor allele frequency in the population database gnomAD v4.1 is 0.002% (1/44,724 alleles) in the East Asian population. This variant has been detected as homozygous and compound heterozygous in at least four unrelated individuals with autosomal recessive polycystic kidney disease, with at least one pathogenic variant confirmed on the second allele (PMID: 27225849, 15108281, 33123899, 35783601). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.7.0, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PM3_Strong, PM2_Supporting, PM5_Supporting. -
Variant summary: The PKHD1 c.11314C>T (p.Arg3772X) variant results in a premature termination codon, predicted to cause a truncated or absent PKHD1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as likely pathogenic in ClinVar (e.g. p.Arg3842Ter and c.11776delG (p.Val3926Trpfs)). This variant is absent in 121176 control chromosomes from ExAC. This variant has been reported in five patients from four ARPKD families (Bergmann_2004, Melchionda_2016; Li_2016), in homozygous state and in compound heterozygous state with known, c.9689delA (p.Asp3230fs) and presumably pathogenic, c.889T>A (p.Cys297Ser) variants. Parents were genotyped in both families and variant transmission in affected offspring's was consistent with disease inheritance. One clinical diagnostic laboratory has classified this variant as likely pathogenic. Taken together, this variant is classified as pathogenic. -
- -
- -
This sequence change creates a premature translational stop signal (p.Arg3772*) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839). This variant is present in population databases (rs199839578, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with polycystic kidney disease (PMID: 15108281, 27225849, 27577217). ClinVar contains an entry for this variant (Variation ID: 370289). For these reasons, this variant has been classified as Pathogenic. -
Polycystic kidney disease 4 Pathogenic:4
- -
PVS1, PS4, PM3 -
- -
PM2_Supporting+PVS1+PM3_VeryStrong -
Inborn genetic diseases Pathogenic:1
The c.11314C>T (p.R3772*) alteration, located in exon 63 (coding exon 62) of the PKHD1 gene, consists of a C to T substitution at nucleotide position 11314. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 3772. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.001% (2/282092) total alleles studied. The highest observed frequency was 0.01% (2/19942) of East Asian alleles. This variant has been identified in the homozygous state and in conjunction with other PKHD1 variants in individuals with features consistent with PKHD1-related polycystic kidney disease; in at least one instance, the variants were identified in trans (Ding, 2024; Shi, 2023; Melchionda, 2016; Bergmann, 2004). Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at